| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 8.02e-07 | 130 | 155 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPC4AP PKD2L1 KCNK9 RYR3 TFRC PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 1.65e-05 | 465 | 155 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CYC1 TRPC4AP PKD2L1 KCNK9 RYR3 TFRC PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 3.09e-05 | 627 | 155 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | endoribonuclease activity, cleaving miRNA-paired mRNA | 5.99e-05 | 2 | 155 | 2 | GO:0090624 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CYC1 TRPC4AP PKD2L1 KCNK9 RYR3 TFRC PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 VDAC3 SLC17A6 | 1.48e-04 | 793 | 155 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | PRPS2 TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C MFN1 TUBA1B TUBA1A THG1L MFN2 | 1.68e-04 | 439 | 155 | 12 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | PRPS2 TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C MFN1 TUBA1B TUBA1A THG1L MFN2 | 1.68e-04 | 439 | 155 | 12 | GO:0019001 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.70e-04 | 36 | 155 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.70e-04 | 36 | 155 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC2 ATP8B4 DYNC2H1 KIF1B BTAF1 ATP10A DDX50 ATP1A2 ATP1A4 DNA2 ATP2A2 ATP2A3 | 1.75e-04 | 441 | 155 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | L-glutamate uniporter activity | 1.79e-04 | 3 | 155 | 2 | GO:0140788 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gi/Go | 1.79e-04 | 3 | 155 | 2 | GO:0001591 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.80e-04 | 151 | 155 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CYC1 TRPC4AP PKD2L1 KCNK9 RYR3 TFRC PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 2.12e-04 | 664 | 155 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CYC1 TRPC4AP PKD2L1 KCNK9 RYR3 TFRC PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 2.78e-04 | 758 | 155 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | GTP binding | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C MFN1 TUBA1B TUBA1A THG1L MFN2 | 2.80e-04 | 397 | 155 | 11 | GO:0005525 |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 3.53e-04 | 78 | 155 | 5 | GO:0051536 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 3.53e-04 | 78 | 155 | 5 | GO:0003725 | |
| GeneOntologyMolecularFunction | carnitine O-palmitoyltransferase activity | 3.56e-04 | 4 | 155 | 2 | GO:0004095 | |
| GeneOntologyMolecularFunction | nuclease activity | 4.55e-04 | 231 | 155 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | metal cluster binding | 4.71e-04 | 83 | 155 | 5 | GO:0051540 | |
| GeneOntologyMolecularFunction | inositol phosphate phosphatase activity | 4.75e-04 | 20 | 155 | 3 | GO:0052745 | |
| GeneOntologyMolecularFunction | miRNA binding | 5.21e-04 | 48 | 155 | 4 | GO:0035198 | |
| GeneOntologyMolecularFunction | O-palmitoyltransferase activity | 5.90e-04 | 5 | 155 | 2 | GO:0016416 | |
| GeneOntologyMolecularFunction | membrane potential driven uniporter activity | 5.90e-04 | 5 | 155 | 2 | GO:0022810 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 5.90e-04 | 5 | 155 | 2 | GO:0004952 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.81e-04 | 136 | 155 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | channel activity | TRPC4AP PKD2L1 KCNK9 RYR3 PTK2B GSDME PKD2L2 SLC17A8 CACNA1H KCNAB3 VDAC3 SLC17A6 | 8.32e-04 | 525 | 155 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPC4AP PKD2L1 KCNK9 RYR3 PTK2B GSDME PKD2L2 SLC17A8 CACNA1H KCNAB3 VDAC3 SLC17A6 | 8.46e-04 | 526 | 155 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | carnitine O-acyltransferase activity | 8.80e-04 | 6 | 155 | 2 | GO:0016406 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPC4AP PKD2L1 KCNK9 RYR3 PTK2B PKD2L2 SLC17A8 CACNA1H KCNAB3 VDAC3 SLC17A6 | 9.36e-04 | 459 | 155 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ERCC2 ATP8B4 DYNC2H1 KIF1B BTAF1 ATP10A DNAH1 DDX50 ATP1A2 ATP1A4 DNA2 ATP2A2 ATP2A3 | 1.02e-03 | 614 | 155 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ERCC2 ATP8B4 DYNC2H1 KIF1B BTAF1 ATP10A MFN1 TUBA1B DDX50 MFN2 ATP1A2 ATP1A4 DNA2 ATP2A2 ATP2A3 | 1.05e-03 | 775 | 155 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.37e-03 | 62 | 155 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 1.37e-03 | 62 | 155 | 4 | GO:0061980 | |
| GeneOntologyMolecularFunction | inositol bisphosphate phosphatase activity | 1.63e-03 | 8 | 155 | 2 | GO:0016312 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.96e-03 | 167 | 155 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 2.08e-03 | 9 | 155 | 2 | GO:0032795 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.21e-03 | 171 | 155 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 2.27e-03 | 172 | 155 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ERCC2 ATP8B4 DYNC2H1 KIF1B BTAF1 ATP10A MFN1 TUBA1B DDX50 MFN2 ATP1A2 ATP1A4 DNA2 ATP2A2 ATP2A3 | 2.28e-03 | 839 | 155 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ERCC2 ATP8B4 DYNC2H1 KIF1B BTAF1 ATP10A MFN1 TUBA1B DDX50 MFN2 ATP1A2 ATP1A4 DNA2 ATP2A2 ATP2A3 | 2.31e-03 | 840 | 155 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ERCC2 ATP8B4 DYNC2H1 KIF1B BTAF1 ATP10A MFN1 TUBA1B DDX50 MFN2 ATP1A2 ATP1A4 DNA2 ATP2A2 ATP2A3 | 2.31e-03 | 840 | 155 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | transporter activity | CYC1 TRPC4AP ATP8B4 PKD2L1 KCNK9 ATP10A RYR3 TFRC PTK2B GSDME PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 VDAC3 SLC17A6 | 2.37e-03 | 1289 | 155 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 2.59e-03 | 10 | 155 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 2.59e-03 | 10 | 155 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | uniporter activity | 2.59e-03 | 10 | 155 | 2 | GO:0015292 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 3.14e-03 | 11 | 155 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 3.14e-03 | 11 | 155 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 3.14e-03 | 11 | 155 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.34e-03 | 79 | 155 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.36e-03 | 129 | 155 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 3.75e-03 | 12 | 155 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 3.83e-03 | 133 | 155 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | AGO2 INPP5A MEIOB PTPRU SLFN14 INPP4B PNPT1 BPNT1 AGO4 AGO3 MARF1 PNPLA8 ATP1A2 DNA2 | 4.16e-03 | 807 | 155 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | endonuclease activity | 4.21e-03 | 136 | 155 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERCC2 AGO2 MEIOB BTAF1 SLFN14 PNPT1 AGO4 AGO3 DDX50 THG1L MARF1 DNA2 | 4.56e-03 | 645 | 155 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CYC1 TRPC4AP PKD2L1 KCNK9 RYR3 TFRC PTK2B GSDME PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 VDAC3 SLC17A6 | 4.68e-03 | 1180 | 155 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | peptide receptor activity | 4.76e-03 | 140 | 155 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | inositol trisphosphate phosphatase activity | 5.12e-03 | 14 | 155 | 2 | GO:0046030 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CLIP2 DYNC2H1 TUBA3D TUBA1C KIF1B SUN1 EML2 TUBA3E NCKAP5 CHEK1 ODF2 TUBA8 TUBA4A TUBA3C GARIN2 DNAH1 TUBA1B BRCA2 TUBA1A TAF7L VPS13A PAK1 IFT122 ATP1A4 VDAC3 | 2.63e-07 | 1058 | 153 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 1.59e-06 | 4 | 153 | 3 | GO:0140766 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 1.59e-06 | 4 | 153 | 3 | GO:0090625 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 6.46e-06 | 132 | 153 | 8 | GO:0035249 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CLIP2 TUBA3D TUBA1C SUN1 EML2 TUBA3E NCKAP5 CHEK1 ODF2 TUBA8 TUBA4A TUBA3C DNAH1 TUBA1B BRCA2 TUBA1A PAK1 | 2.59e-05 | 720 | 153 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | calcium ion transport | IL16 TRPC4AP DRD2 DRD3 GAS6 PKD2L1 RYR3 CD84 PTK2B PKD2L2 CACNA1H ATP1A2 ATP2A2 ATP2A3 | 2.71e-05 | 509 | 153 | 14 | GO:0006816 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter uptake | 2.76e-05 | 24 | 153 | 4 | GO:0051580 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 3.25e-05 | 9 | 153 | 3 | GO:0010501 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 3.26e-05 | 25 | 153 | 4 | GO:0051481 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | TRPC4AP DRD2 DRD3 GAS6 PKD2L1 RYR3 PTK2B PKD2L2 CACNA1H ATP1A2 ATP2A2 ATP2A3 | 3.73e-05 | 392 | 153 | 12 | GO:0070588 |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 4.13e-05 | 52 | 153 | 5 | GO:0001504 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 4.62e-05 | 10 | 153 | 3 | GO:0070922 | |
| GeneOntologyBiologicalProcess | metal ion transport | IL16 TRPC4AP DRD2 DRD3 GAS6 PKD2L1 KCNK9 RYR3 TFRC CD84 PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 5.18e-05 | 1000 | 153 | 20 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 5.47e-05 | 2 | 153 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | DRD2 DRD3 IREB2 INPP4B RYR3 FBXL5 TFRC PTK2B SLC17A8 MFN2 ATP1A2 ATP1A4 ATP2A2 ATP2A3 SLC17A6 | 6.26e-05 | 622 | 153 | 15 | GO:0098771 |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 7.63e-05 | 59 | 153 | 5 | GO:0045761 | |
| GeneOntologyBiologicalProcess | neuron-neuron synaptic transmission | 8.38e-05 | 12 | 153 | 3 | GO:0007270 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CYC1 IL16 TRPC4AP DRD2 DRD3 GAS6 PKD2L1 KCNK9 RYR3 TFRC CD84 PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 1.32e-04 | 1157 | 153 | 21 | GO:0006812 |
| GeneOntologyBiologicalProcess | mitochondrial fusion | 1.59e-04 | 37 | 153 | 4 | GO:0008053 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 1.61e-04 | 69 | 153 | 5 | GO:0031279 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CYC1 TRPC4AP DRD2 DRD3 GAS6 PKD2L1 KCNK9 RYR3 PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 1.70e-04 | 922 | 153 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 1.77e-04 | 38 | 153 | 4 | GO:0098810 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CCNI2 ERCC2 DRD3 CENPF TUBA3D TUBA1C TUBA3E CHEK1 TUBA8 TUBA4A TUBA3C BTN2A1 TUBA1B BRCA2 TUBA1A BTG1 MKI67 SMARCD1 DNA2 | 1.88e-04 | 1014 | 153 | 19 | GO:0000278 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | DRD2 DRD3 IREB2 INPP4B RYR3 DMXL1 FBXL5 TFRC PTK2B MFN2 ATP1A2 ATP1A4 ATP2A2 ATP2A3 | 1.89e-04 | 611 | 153 | 14 | GO:0030003 |
| GeneOntologyBiologicalProcess | potassium ion transport | 2.02e-04 | 272 | 153 | 9 | GO:0006813 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CYC1 IL16 TRPC4AP DRD2 DRD3 GAS6 PKD2L1 KCNK9 ATP10A RYR3 TFRC CD84 PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 VDAC3 SLC17A6 | 2.03e-04 | 1374 | 153 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 2.11e-04 | 73 | 153 | 5 | GO:0051339 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CYC1 TRPC4AP DRD2 DRD3 GAS6 PKD2L1 KCNK9 RYR3 PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 2.22e-04 | 942 | 153 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | long-chain fatty acid transport | 2.24e-04 | 74 | 153 | 5 | GO:0015909 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CYC1 TRPC4AP DRD2 DRD3 GAS6 PKD2L1 KCNK9 ATP10A RYR3 PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 VDAC3 SLC17A6 | 2.25e-04 | 1115 | 153 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | DRD2 DRD3 IREB2 INPP4B RYR3 DMXL1 FBXL5 TFRC PTK2B MFN2 ATP1A2 ATP1A4 ATP2A2 ATP2A3 | 2.27e-04 | 622 | 153 | 14 | GO:0006873 |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 2.29e-04 | 116 | 153 | 6 | GO:0008344 | |
| GeneOntologyBiologicalProcess | pre-miRNA processing | 2.52e-04 | 17 | 153 | 3 | GO:0031054 | |
| GeneOntologyBiologicalProcess | negative regulation of dopamine receptor signaling pathway | 3.25e-04 | 4 | 153 | 2 | GO:0060160 | |
| GeneOntologyBiologicalProcess | regulation of glutamate uptake involved in transmission of nerve impulse | 3.25e-04 | 4 | 153 | 2 | GO:0051946 | |
| GeneOntologyBiologicalProcess | regulation of amino acid uptake involved in synaptic transmission | 3.25e-04 | 4 | 153 | 2 | GO:0051941 | |
| GeneOntologyBiologicalProcess | positive regulation of glomerular filtration | 3.25e-04 | 4 | 153 | 2 | GO:0003104 | |
| GeneOntologyBiologicalProcess | carnitine shuttle | 3.25e-04 | 4 | 153 | 2 | GO:0006853 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 3.43e-04 | 125 | 153 | 6 | GO:0043279 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 3.73e-04 | 46 | 153 | 4 | GO:0051938 | |
| GeneOntologyBiologicalProcess | response to manganese ion | 4.83e-04 | 21 | 153 | 3 | GO:0010042 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 5.39e-04 | 5 | 153 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CYC1 TRPC4AP DRD2 DRD3 GAS6 PKD2L1 KCNK9 RYR3 PTK2B PKD2L2 SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 ATP2A3 KCNAB3 SLC17A6 | 5.53e-04 | 1017 | 153 | 18 | GO:0098660 |
| GeneOntologyCellularComponent | microtubule | EFCAB6 CLIP2 DYNC2H1 TUBA3D TUBA1C KIF1B EML2 TUBA3E NCKAP5 ODF2 TUBA8 TUBA4A TUBA3C DNAH1 TUBA1B TUBA1A | 2.99e-06 | 533 | 158 | 16 | GO:0005874 |
| GeneOntologyCellularComponent | RISC-loading complex | 4.89e-05 | 10 | 158 | 3 | GO:0070578 | |
| GeneOntologyCellularComponent | pericellular basket | 1.69e-04 | 3 | 158 | 2 | GO:1990030 | |
| GeneOntologyCellularComponent | supramolecular fiber | EFCAB6 CLIP2 DYNC2H1 TUBA3D TUBA1C KIF1B EML2 TUBA3E NCKAP5 ODF2 TUBA8 TUBA4A TUBA3C RYR3 DNAH1 TUBA1B FBN2 TUBA1A XIRP2 SPHKAP PAK1 | 2.24e-04 | 1179 | 158 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | EFCAB6 CLIP2 DYNC2H1 TUBA3D TUBA1C KIF1B EML2 TUBA3E NCKAP5 ODF2 TUBA8 TUBA4A TUBA3C RYR3 DNAH1 TUBA1B FBN2 TUBA1A XIRP2 SPHKAP PAK1 | 2.45e-04 | 1187 | 158 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | transporter complex | CYC1 ATP8B4 PKD2L1 ATP10A RYR3 PTK2B SLC17A8 CACNA1H ATP1A2 ATP1A4 ATP2A2 KCNAB3 SLC17A6 | 2.88e-04 | 550 | 158 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EFCAB6 CLIP2 DYNC2H1 TUBA3D TUBA1C KIF1B EML2 TUBA3E NCKAP5 ODF2 TUBA8 TUBA4A TUBA3C DNAH1 TUBA1B TUBA1A PAK1 | 4.71e-04 | 899 | 158 | 17 | GO:0099513 |
| MousePheno | increased thyrotroph cell number | 1.54e-05 | 6 | 130 | 3 | MP:0008337 | |
| Domain | Alpha_tubulin | 9.20e-14 | 9 | 157 | 7 | IPR002452 | |
| Domain | Tubulin_C | 3.98e-10 | 22 | 157 | 7 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 3.98e-10 | 22 | 157 | 7 | IPR018316 | |
| Domain | Tubulin_C | 3.98e-10 | 22 | 157 | 7 | SM00865 | |
| Domain | Tub_FtsZ_C | 5.68e-10 | 23 | 157 | 7 | IPR008280 | |
| Domain | Tubulin_C | 5.68e-10 | 23 | 157 | 7 | IPR023123 | |
| Domain | TUBULIN | 5.68e-10 | 23 | 157 | 7 | PS00227 | |
| Domain | Tubulin | 5.68e-10 | 23 | 157 | 7 | IPR000217 | |
| Domain | Tubulin | 5.68e-10 | 23 | 157 | 7 | SM00864 | |
| Domain | Tubulin_CS | 5.68e-10 | 23 | 157 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 7.96e-10 | 24 | 157 | 7 | IPR003008 | |
| Domain | Tubulin | 7.96e-10 | 24 | 157 | 7 | PF00091 | |
| Domain | - | 1.13e-08 | 20 | 157 | 6 | 3.30.1330.20 | |
| Domain | - | 1.57e-08 | 21 | 157 | 6 | 1.10.287.600 | |
| Domain | - | 2.14e-08 | 22 | 157 | 6 | 3.40.50.1440 | |
| Domain | - | 2.42e-07 | 32 | 157 | 6 | 3.40.1110.10 | |
| Domain | - | 2.42e-07 | 32 | 157 | 6 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 4.25e-07 | 35 | 157 | 6 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 5.07e-07 | 36 | 157 | 6 | IPR018303 | |
| Domain | P_typ_ATPase | 5.07e-07 | 36 | 157 | 6 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.07e-07 | 36 | 157 | 6 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 6.01e-07 | 37 | 157 | 6 | IPR008250 | |
| Domain | E1-E2_ATPase | 6.01e-07 | 37 | 157 | 6 | PF00122 | |
| Domain | Hydrolase_3 | 9.70e-07 | 10 | 157 | 4 | PF08282 | |
| Domain | Argonaute_N | 2.32e-06 | 4 | 157 | 3 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 2.32e-06 | 4 | 157 | 3 | IPR032473 | |
| Domain | ArgoL2 | 2.32e-06 | 4 | 157 | 3 | IPR032472 | |
| Domain | PBC | 2.32e-06 | 4 | 157 | 3 | PF03792 | |
| Domain | PBX | 2.32e-06 | 4 | 157 | 3 | IPR005542 | |
| Domain | ArgoN | 2.32e-06 | 4 | 157 | 3 | PF16486 | |
| Domain | ArgoMid | 2.32e-06 | 4 | 157 | 3 | PF16487 | |
| Domain | ArgoL2 | 2.32e-06 | 4 | 157 | 3 | PF16488 | |
| Domain | DUF1785 | 5.76e-06 | 5 | 157 | 3 | SM01163 | |
| Domain | ATPase_P-typ_TM_dom | 8.08e-06 | 16 | 157 | 4 | IPR023298 | |
| Domain | - | 8.08e-06 | 16 | 157 | 4 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.05e-05 | 17 | 157 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.05e-05 | 17 | 157 | 4 | PF00689 | |
| Domain | ArgoL1 | 1.14e-05 | 6 | 157 | 3 | PF08699 | |
| Domain | ArgoL1 | 1.14e-05 | 6 | 157 | 3 | IPR014811 | |
| Domain | Cation_ATPase_N | 1.34e-05 | 18 | 157 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 1.34e-05 | 18 | 157 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.69e-05 | 19 | 157 | 4 | IPR004014 | |
| Domain | PIWI | 3.16e-05 | 8 | 157 | 3 | PS50822 | |
| Domain | Piwi | 3.16e-05 | 8 | 157 | 3 | SM00950 | |
| Domain | Piwi | 3.16e-05 | 8 | 157 | 3 | PF02171 | |
| Domain | Piwi | 3.16e-05 | 8 | 157 | 3 | IPR003165 | |
| Domain | PAZ | 4.72e-05 | 9 | 157 | 3 | PS50821 | |
| Domain | PAZ | 4.72e-05 | 9 | 157 | 3 | SM00949 | |
| Domain | PAZ | 4.72e-05 | 9 | 157 | 3 | PF02170 | |
| Domain | PAZ_dom | 4.72e-05 | 9 | 157 | 3 | IPR003100 | |
| Domain | HAD-like_dom | 5.37e-05 | 79 | 157 | 6 | IPR023214 | |
| Domain | Fzo_mitofusin | 7.02e-05 | 2 | 157 | 2 | PF04799 | |
| Domain | Mitofusin_fam | 7.02e-05 | 2 | 157 | 2 | IPR027094 | |
| Domain | Relaxin_rcpt | 7.02e-05 | 2 | 157 | 2 | IPR008112 | |
| Domain | Fzo/mitofusin_HR2 | 7.02e-05 | 2 | 157 | 2 | IPR006884 | |
| Domain | P-type_ATPase_IIA | 2.09e-04 | 3 | 157 | 2 | IPR005782 | |
| Domain | PC1 | 4.17e-04 | 4 | 157 | 2 | IPR000434 | |
| Domain | PKD_2 | 6.91e-04 | 5 | 157 | 2 | IPR003915 | |
| Domain | Dopamine_rcpt | 6.91e-04 | 5 | 157 | 2 | IPR000929 | |
| Domain | P-type_ATPase_IIC | 1.03e-03 | 6 | 157 | 2 | IPR005775 | |
| Domain | cEGF | 1.31e-03 | 26 | 157 | 3 | PF12662 | |
| Domain | cEGF | 1.31e-03 | 26 | 157 | 3 | IPR026823 | |
| Domain | Carn_acyl_trans | 1.43e-03 | 7 | 157 | 2 | IPR000542 | |
| Domain | Carn_acyltransf | 1.43e-03 | 7 | 157 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 1.43e-03 | 7 | 157 | 2 | PS00439 | |
| Domain | ACYLTRANSF_C_2 | 1.43e-03 | 7 | 157 | 2 | PS00440 | |
| Domain | PKD_channel | 3.67e-03 | 11 | 157 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 3.67e-03 | 11 | 157 | 2 | IPR013122 | |
| Domain | ARM_REPEAT | 4.58e-03 | 40 | 157 | 3 | PS50176 | |
| Domain | ARM | 4.58e-03 | 40 | 157 | 3 | SM00185 | |
| Domain | - | 5.86e-03 | 321 | 157 | 8 | 3.80.10.10 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.98e-03 | 14 | 157 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.98e-03 | 14 | 157 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.98e-03 | 14 | 157 | 2 | IPR013602 | |
| Domain | G_DYNAMIN_dom | 5.98e-03 | 14 | 157 | 2 | IPR030381 | |
| Domain | DHC_N2 | 5.98e-03 | 14 | 157 | 2 | PF08393 | |
| Domain | P_typ_ATPase_c | 5.98e-03 | 14 | 157 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 5.98e-03 | 14 | 157 | 2 | IPR032631 | |
| Domain | ATPase_dyneun-rel_AAA | 5.98e-03 | 14 | 157 | 2 | IPR011704 | |
| Domain | P-type_ATPase_IV | 5.98e-03 | 14 | 157 | 2 | IPR006539 | |
| Domain | MT | 5.98e-03 | 14 | 157 | 2 | PF12777 | |
| Domain | AAA_8 | 5.98e-03 | 14 | 157 | 2 | PF12780 | |
| Domain | PhoLip_ATPase_C | 5.98e-03 | 14 | 157 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 5.98e-03 | 14 | 157 | 2 | PF16209 | |
| Domain | G_DYNAMIN_2 | 5.98e-03 | 14 | 157 | 2 | PS51718 | |
| Domain | AAA_5 | 5.98e-03 | 14 | 157 | 2 | PF07728 | |
| Domain | L_dom-like | 6.64e-03 | 328 | 157 | 8 | IPR032675 | |
| Domain | - | 6.79e-03 | 46 | 157 | 3 | 4.10.400.10 | |
| Domain | DHC_fam | 6.86e-03 | 15 | 157 | 2 | IPR026983 | |
| Domain | Dynamin_GTPase | 6.86e-03 | 15 | 157 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 6.86e-03 | 15 | 157 | 2 | IPR022812 | |
| Domain | Dynein_heavy | 6.86e-03 | 15 | 157 | 2 | PF03028 | |
| Domain | Dynamin_N | 6.86e-03 | 15 | 157 | 2 | PF00350 | |
| Domain | Dynein_heavy_dom | 6.86e-03 | 15 | 157 | 2 | IPR004273 | |
| Domain | Armadillo | 7.21e-03 | 47 | 157 | 3 | IPR000225 | |
| Domain | - | 7.21e-03 | 47 | 157 | 3 | 3.30.420.10 | |
| Domain | ARM-like | 7.93e-03 | 270 | 157 | 7 | IPR011989 | |
| Domain | ARM-type_fold | 8.03e-03 | 339 | 157 | 8 | IPR016024 | |
| Domain | Leu-rich_rpt | 8.09e-03 | 271 | 157 | 7 | IPR001611 | |
| Domain | LDrepeatLR_classA_rpt | 8.09e-03 | 49 | 157 | 3 | IPR002172 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | CENPF TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 3.13e-14 | 20 | 122 | 9 | M47890 |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | CLIP2 TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 9.14e-14 | 22 | 122 | 9 | M47903 |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 5.68e-13 | 17 | 122 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.02e-12 | 18 | 122 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.74e-12 | 19 | 122 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.74e-12 | 19 | 122 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.88e-12 | 20 | 122 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.62e-12 | 21 | 122 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.62e-12 | 21 | 122 | 8 | M47767 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.10e-11 | 23 | 122 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.10e-11 | 23 | 122 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.10e-11 | 23 | 122 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.63e-11 | 24 | 122 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.63e-11 | 24 | 122 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.39e-11 | 25 | 122 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.39e-11 | 25 | 122 | 8 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 3.42e-11 | 26 | 122 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.42e-11 | 26 | 122 | 8 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 6.71e-11 | 28 | 122 | 8 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C DNAH1 TUBA1B TUBA1A | 8.90e-11 | 43 | 122 | 9 | M47669 |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | DYNC2H1 TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 8.90e-11 | 43 | 122 | 9 | M47773 |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 9.20e-11 | 29 | 122 | 8 | M27948 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A LRRC7 | 1.11e-10 | 44 | 122 | 9 | M27934 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C DNAH1 TUBA1B TUBA1A | 1.38e-10 | 45 | 122 | 9 | M47670 |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.21e-10 | 32 | 122 | 8 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.21e-10 | 32 | 122 | 8 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.89e-10 | 33 | 122 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.89e-10 | 33 | 122 | 8 | M47901 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C MFN1 TUBA1B TUBA1A MFN2 VDAC3 | 3.02e-10 | 90 | 122 | 11 | M29841 |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 4.83e-10 | 35 | 122 | 8 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 9.82e-10 | 38 | 122 | 8 | M14981 | |
| Pathway | REACTOME_KINESINS | TUBA3D TUBA1C KIF1B TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 2.40e-09 | 61 | 122 | 9 | M977 |
| Pathway | REACTOME_AGGREPHAGY | 3.41e-09 | 44 | 122 | 8 | M29830 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.25e-09 | 17 | 122 | 6 | MM14731 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 4.95e-09 | 46 | 122 | 8 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 8.37e-09 | 49 | 122 | 8 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.16e-08 | 51 | 122 | 8 | M26972 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.23e-08 | 73 | 122 | 9 | MM15672 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.60e-08 | 53 | 122 | 8 | M27651 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.86e-08 | 54 | 122 | 8 | M27482 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.16e-08 | 55 | 122 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.51e-08 | 56 | 122 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.89e-08 | 57 | 122 | 8 | M27251 | |
| Pathway | KEGG_GAP_JUNCTION | 7.93e-08 | 90 | 122 | 9 | M4013 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 9.47e-08 | 27 | 122 | 6 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 9.47e-08 | 27 | 122 | 6 | MM15674 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A LRRC7 | 1.16e-07 | 94 | 122 | 9 | M2843 |
| Pathway | REACTOME_AUTOPHAGY | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C MFN1 TUBA1B TUBA1A MFN2 VDAC3 | 1.19e-07 | 158 | 122 | 11 | M27935 |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.27e-07 | 95 | 122 | 9 | M6729 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.50e-07 | 29 | 122 | 6 | MM15219 | |
| Pathway | REACTOME_PROTEIN_FOLDING | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C FBXL5 TUBA1B TUBA1A | 1.67e-07 | 98 | 122 | 9 | M776 |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.68e-07 | 71 | 122 | 8 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.88e-07 | 72 | 122 | 8 | M26954 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | TUBA3D TUBA1C KIF1B TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 1.99e-07 | 100 | 122 | 9 | M27650 |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | TUBA3D TUBA1C KIF1B TUBA3E TUBA8 TUBA4A TUBA3C MFN1 TUBA1B TUBA1A MFN2 | 2.51e-07 | 170 | 122 | 11 | M941 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.80e-07 | 32 | 122 | 6 | MM14730 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.88e-07 | 76 | 122 | 8 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.88e-07 | 76 | 122 | 8 | M27215 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.96e-07 | 52 | 122 | 7 | MM15211 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.90e-07 | 79 | 122 | 8 | M27743 | |
| Pathway | REACTOME_KINESINS | 5.65e-07 | 57 | 122 | 7 | MM15714 | |
| Pathway | REACTOME_AGGREPHAGY | 5.85e-07 | 36 | 122 | 6 | MM15669 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 6.25e-07 | 20 | 122 | 5 | MM1383 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 6.93e-07 | 37 | 122 | 6 | MM15102 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 7.09e-07 | 116 | 122 | 9 | MM15715 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.01e-06 | 121 | 122 | 9 | M872 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | DYNC2H1 TUBA3D TUBA1C TUBA3E ODF2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A IFT122 | 1.33e-06 | 201 | 122 | 11 | M27472 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | CENPF TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 1.52e-06 | 127 | 122 | 9 | M27181 |
| Pathway | REACTOME_MACROAUTOPHAGY | 1.85e-06 | 130 | 122 | 9 | MM14627 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.91e-06 | 68 | 122 | 7 | MM14968 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.00e-06 | 44 | 122 | 6 | MM14606 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | TUBA3D TUBA1C KIF1B TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 2.38e-06 | 134 | 122 | 9 | M27751 |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C RYR3 TUBA1B TUBA1A ATP2A2 ATP2A3 VDAC3 | 2.69e-06 | 261 | 122 | 12 | M42565 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.78e-06 | 102 | 122 | 8 | M27648 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.39e-06 | 48 | 122 | 6 | MM15353 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | CENPF TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 3.42e-06 | 140 | 122 | 9 | M27550 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.46e-06 | 52 | 122 | 6 | MM14949 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 5.99e-06 | 113 | 122 | 8 | M27471 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 6.24e-06 | 5 | 122 | 3 | M22079 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B KPNA7 TUBA1A | 6.37e-06 | 151 | 122 | 9 | M550 |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.61e-06 | 55 | 122 | 6 | M971 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | CENPF TUBA3D TUBA1C TUBA3E ODF2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 9.16e-06 | 200 | 122 | 10 | M864 |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 9.40e-06 | 57 | 122 | 6 | MM15643 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | CENPF TUBA3D TUBA1C TUBA3E ODF2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 1.09e-05 | 204 | 122 | 10 | M4217 |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 1.24e-05 | 6 | 122 | 3 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.24e-05 | 6 | 122 | 3 | MM15083 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.26e-05 | 90 | 122 | 7 | MM14979 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.34e-05 | 126 | 122 | 8 | M705 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 2.16e-05 | 7 | 122 | 3 | M46421 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.21e-05 | 98 | 122 | 7 | MM15352 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.21e-05 | 66 | 122 | 6 | MM17074 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3D TUBA1C TUBA3E TRIM34 TUBA8 TUBA4A TUBA3C TUBA1B KPNA7 TUBA1A TRIM8 | 2.46e-05 | 273 | 122 | 11 | M983 |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C RYR3 TUBA1B TUBA1A ATP2A2 ATP2A3 VDAC3 | 2.55e-05 | 326 | 122 | 12 | M39379 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 2.59e-05 | 138 | 122 | 8 | M29805 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.62e-05 | 68 | 122 | 6 | MM14921 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 3.43e-05 | 8 | 122 | 3 | MM15082 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.45e-05 | 105 | 122 | 7 | MM15206 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 3.53e-05 | 187 | 122 | 9 | M961 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.94e-05 | 73 | 122 | 6 | MM15491 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | CENPF TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 4.16e-05 | 191 | 122 | 9 | M29614 |
| Pubmed | 1.75e-18 | 9 | 163 | 8 | 21167302 | ||
| Pubmed | 1.42e-14 | 19 | 163 | 8 | 15698476 | ||
| Pubmed | 1.42e-14 | 19 | 163 | 8 | 15691386 | ||
| Pubmed | 5.92e-14 | 22 | 163 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 2.68e-13 | 8 | 163 | 6 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 7.01e-12 | 22 | 163 | 7 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 8.72e-12 | 12 | 163 | 6 | 15331610 | |
| Pubmed | 1.27e-11 | 6 | 163 | 5 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.27e-11 | 6 | 163 | 5 | 7651436 | |
| Pubmed | 1.27e-11 | 6 | 163 | 5 | 16327313 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.61e-11 | 13 | 163 | 6 | 10908577 | |
| Pubmed | 2.81e-11 | 14 | 163 | 6 | 12486001 | ||
| Pubmed | 4.43e-11 | 7 | 163 | 5 | 11146551 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 2.64e-10 | 9 | 163 | 5 | 11953448 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 18400243 | ||
| Pubmed | 6.77e-10 | 22 | 163 | 6 | 15103018 | ||
| Pubmed | 1.26e-08 | 17 | 163 | 5 | 17360745 | ||
| Pubmed | 1.55e-08 | 94 | 163 | 8 | 36584595 | ||
| Pubmed | 1.61e-08 | 7 | 163 | 4 | 36681692 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CYC1 PCLO KIF1B TUBA8 CBR1 TUBA1B PTK2B EPS15L1 BRCA2 TUBA1A MFN2 LRRC7 ATP1A4 ATP2A2 ATP2A3 VDAC3 | 4.34e-08 | 621 | 163 | 16 | 22794259 |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 5.25e-08 | 22 | 163 | 5 | 30446499 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 11163133 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 1.01e-07 | 3 | 163 | 3 | 9722999 | |
| Pubmed | IHG-1 increases mitochondrial fusion and bioenergetic function. | 1.01e-07 | 3 | 163 | 3 | 25008184 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPC4AP HIVEP2 AGO2 INPP5A KIF1B GAS6 GPATCH2 FRYL BTAF1 CPT1A ATP10A DNAH1 PACS1 EPS15L1 BANP CISD3 CACNA1H LRRC7 DHRSX IFT122 PBX2 PBX3 MARCHF1 FRMD3 | 1.32e-07 | 1489 | 163 | 24 | 28611215 |
| Pubmed | TUBA3E TUBA8 TUBA4A TUBA3C MFN1 TUBA1B DDX50 TUBA1A ASXL3 TAF7L HACE1 CACNA1H OXSM ATP2A3 | 1.57e-07 | 513 | 163 | 14 | 25798074 | |
| Pubmed | 2.31e-07 | 29 | 163 | 5 | 15071553 | ||
| Pubmed | 3.22e-07 | 13 | 163 | 4 | 14697242 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | TUBA1C TUBA4A TFRC TUBA1B EPS15L1 TUBA1A VPS13A PRKCSH ATP2A2 ATP2A3 | 4.02e-07 | 256 | 163 | 10 | 24189400 |
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 4.03e-07 | 4 | 163 | 3 | 23748378 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 28714470 | ||
| Pubmed | Argonaute proteins: potential biomarkers for human colon cancer. | 4.03e-07 | 4 | 163 | 3 | 20146808 | |
| Pubmed | Slicing-independent RISC activation requires the argonaute PAZ domain. | 4.03e-07 | 4 | 163 | 3 | 22795694 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 19966796 | ||
| Pubmed | Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. | 4.03e-07 | 4 | 163 | 3 | 18771919 | |
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 4.03e-07 | 4 | 163 | 3 | 15260970 | |
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 19393748 | ||
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 19324964 | ||
| Pubmed | Transcription factor PBX4 regulates limb development and haematopoiesis in mice. | 1.00e-06 | 5 | 163 | 3 | 38230761 | |
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 12526743 | ||
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 12414724 | ||
| Pubmed | Differential expression of components of the microRNA machinery during mouse organogenesis. | 1.00e-06 | 5 | 163 | 3 | 16036130 | |
| Pubmed | Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. | 1.00e-06 | 5 | 163 | 3 | 11335119 | |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 1.11e-06 | 113 | 163 | 7 | 34474245 | |
| Pubmed | 1.61e-06 | 76 | 163 | 6 | 27542412 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CYC1 PRPS2 ERCC2 AGO2 CAND2 TUBA1C BTAF1 SSR4 CPT1A BIRC6 TUBA4A TUBA3C GTF3C3 TFRC TUBA1B TUBA1A MFN2 DNA2 ATP2A2 VDAC3 | 1.97e-06 | 1257 | 163 | 20 | 37317656 |
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 7744867 | ||
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 18613978 | ||
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 12090300 | ||
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 10840040 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 2.19e-06 | 125 | 163 | 7 | 36030824 | |
| Pubmed | 2.62e-06 | 21 | 163 | 4 | 36332009 | ||
| Pubmed | HIVEP2 CLIP2 DYNC2H1 TUBA1C TUBA4A TUBA1B TUBA1A MARF1 SMARCD1 KLHL12 | 3.18e-06 | 322 | 163 | 10 | 26514267 | |
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 19383768 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 3.49e-06 | 7 | 163 | 3 | 19470757 | |
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 34907157 | ||
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 19536157 | ||
| Pubmed | CYC1 MAPK8IP1 IL16 AGO2 CLIP2 PCLO PKP4 TUBA1C KIF1B CBR1 TUBA4A PTK2B PACS1 DZANK1 EPS15L1 TUBA1A DLST LRRC7 ATP1A2 ATP2A2 VDAC3 | 3.80e-06 | 1431 | 163 | 21 | 37142655 | |
| Pubmed | FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem Progenitor Cells. | 5.45e-06 | 25 | 163 | 4 | 28069738 | |
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 29021386 | ||
| Pubmed | Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis. | 5.56e-06 | 8 | 163 | 3 | 19345100 | |
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 23060438 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 5.56e-06 | 8 | 163 | 3 | 19033399 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | TUBA1C TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A MKI67 ATP1A4 TP53BP1 | 5.83e-06 | 271 | 163 | 9 | 32433965 |
| Pubmed | 6.01e-06 | 272 | 163 | 9 | 31010829 | ||
| Pubmed | 7.55e-06 | 99 | 163 | 6 | 29676259 | ||
| Pubmed | 7.72e-06 | 212 | 163 | 8 | 23463506 | ||
| Pubmed | 8.32e-06 | 9 | 163 | 3 | 19103752 | ||
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 8.32e-06 | 9 | 163 | 3 | 12906857 | |
| Pubmed | MYT1L MAPK8IP1 HIVEP2 CLIP2 KIF1B NCKAP5 ODF2 CBR1 RYR3 TUBA1B EPS15L1 TRIM8 PAK1 DLST IFT122 ATP1A2 PBX2 PBX3 ATP2A2 | 1.03e-05 | 1285 | 163 | 19 | 35914814 | |
| Pubmed | 1.18e-05 | 296 | 163 | 9 | 34186245 | ||
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 1.62e-05 | 11 | 163 | 3 | 20405035 | |
| Pubmed | 1.62e-05 | 67 | 163 | 5 | 30669930 | ||
| Pubmed | Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. | 1.71e-05 | 33 | 163 | 4 | 22904094 | |
| Pubmed | 1.84e-05 | 239 | 163 | 8 | 23246001 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12834818 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22970199 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12604689 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20970071 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31431479 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 27349735 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29212658 | ||
| Pubmed | Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD. | 2.18e-05 | 2 | 163 | 2 | 11425949 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20188195 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31538542 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33318558 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17175177 | ||
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 2.18e-05 | 2 | 163 | 2 | 24268707 | |
| Pubmed | Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice. | 2.18e-05 | 2 | 163 | 2 | 22028476 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22511781 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19052620 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12297539 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19650915 | ||
| Pubmed | Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence. | 2.18e-05 | 2 | 163 | 2 | 16094250 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19011428 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20301684 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15537671 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25217043 | ||
| Pubmed | Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. | 2.18e-05 | 2 | 163 | 2 | 21663922 | |
| Interaction | TCP11L2 interactions | 1.69e-10 | 21 | 158 | 7 | int:TCP11L2 | |
| Interaction | GRM7 interactions | 2.96e-07 | 19 | 158 | 5 | int:GRM7 | |
| Interaction | SSR2 interactions | 1.53e-06 | 46 | 158 | 6 | int:SSR2 | |
| Interaction | BSG interactions | CAND2 TUBA3D TUBA1C FASTKD1 FNDC5 TUBA3E BTAF1 TUBA8 F2RL1 TUBA4A TUBA3C TFRC TUBA1B TUBA1A ARMC5 PRKCSH ATP2A2 VDAC3 | 2.39e-06 | 631 | 158 | 18 | int:BSG |
| Interaction | CAPSL interactions | 4.64e-06 | 15 | 158 | 4 | int:CAPSL | |
| Interaction | CD81 interactions | TUBA3D TUBA1C FNDC5 TUBA3E TSHR TUBA8 F2RL1 TUBA4A TUBA3C TFRC TUBA1B TUBA1A | 5.01e-06 | 303 | 158 | 12 | int:CD81 |
| Interaction | PPP4R1L interactions | 5.51e-06 | 87 | 158 | 7 | int:PPP4R1L | |
| Interaction | PTEN interactions | TUBA1C CHEK1 SSR4 BIRC6 TUBA3C GTF3C3 RYR3 FBXL5 TRAPPC13 TUBA1B PTK2B QRFPR FBN2 DDX50 TUBA1A MKI67 TRIM8 PBX3 ATP2A2 TP53BP1 VDAC3 | 1.25e-05 | 929 | 158 | 21 | int:PTEN |
| Interaction | NPTN interactions | CAND2 DYNC2H1 TUBA1C FASTKD1 FNDC5 BTAF1 CPT1A TUBA4A MFN1 TUBA1A ATP2A2 | 1.27e-05 | 278 | 158 | 11 | int:NPTN |
| Interaction | PAK1 interactions | CYC1 PRPS2 TUBA1C TUBA3E CPT1A TUBA3C TUBA1B TUBA1A HACE1 PAK1 | 1.36e-05 | 229 | 158 | 10 | int:PAK1 |
| Interaction | NUP210P1 interactions | 1.87e-05 | 42 | 158 | 5 | int:NUP210P1 | |
| Interaction | NLRP1 interactions | 3.27e-05 | 47 | 158 | 5 | int:NLRP1 | |
| Interaction | C5orf24 interactions | 3.63e-05 | 48 | 158 | 5 | int:C5orf24 | |
| Interaction | ATOH1 interactions | 3.93e-05 | 80 | 158 | 6 | int:ATOH1 | |
| Interaction | LTA interactions | 6.43e-05 | 28 | 158 | 4 | int:LTA | |
| Interaction | P2RY8 interactions | 8.59e-05 | 179 | 158 | 8 | int:P2RY8 | |
| GeneFamily | Tubulins | 3.19e-12 | 26 | 116 | 8 | 778 | |
| GeneFamily | Argonaute/PIWI family | 1.41e-05 | 8 | 116 | 3 | 408 | |
| GeneFamily | Relaxin family peptide receptors | 2.43e-04 | 4 | 116 | 2 | 217 | |
| GeneFamily | Dopamine receptors | 4.03e-04 | 5 | 116 | 2 | 181 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 6.01e-04 | 26 | 116 | 3 | 526 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 8.39e-04 | 7 | 116 | 2 | 1208 | |
| GeneFamily | Phosphoinositide phosphatases | 1.11e-03 | 32 | 116 | 3 | 1079 | |
| GeneFamily | ATPases Ca2+ transporting | 1.43e-03 | 9 | 116 | 2 | 1209 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.63e-03 | 43 | 116 | 3 | 409 | |
| GeneFamily | ATPase phospholipid transporting | 4.06e-03 | 15 | 116 | 2 | 1210 | |
| Coexpression | E2F1_UP.V1_UP | ERCC2 AGO2 PKP4 CHEK1 PTPRU PACS1 GSDME BRCA2 ZSWIM7 PBX3 DNA2 | 2.36e-08 | 188 | 160 | 11 | M2632 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CENPF MEIOB TUBA3E ALS2 CHEK1 ATP10A DMXL1 FBXL5 TFRC BPNT1 BRCA2 TAF7L EIF2B3 HACE1 ATF7IP2 VPS13A PAK1 ZSWIM7 DNA2 | 1.40e-05 | 820 | 160 | 19 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | CENPF MEIOB TUBA3E ALS2 CHEK1 ATP10A GTF3C3 FBXL5 TFRC BPNT1 BRCA2 TAF7L EIF2B3 ATF7IP2 VPS13A PAK1 KLHL12 ZSWIM7 DNA2 | 1.44e-05 | 822 | 160 | 19 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | CENPF TUBA3E ALS2 CHEK1 FBXL5 TFRC BPNT1 BRCA2 EIF2B3 ATF7IP2 PAK1 ZSWIM7 | 1.96e-05 | 361 | 160 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.17e-05 | 210 | 160 | 9 | gudmap_developingGonad_e14.5_ ovary_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | CENPF MEIOB TUBA3E CHEK1 TFRC BPNT1 BRCA2 TAF7L EIF2B3 ATF7IP2 VPS13A PAK1 | 3.69e-05 | 385 | 160 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ATP8B4 LRRIQ3 PKP4 KIF1B MEIOB TUBA3E CHEK1 BIRC6 DMXL1 GSDME AGO3 HMCN1 BRCA2 TAF7L THG1L ATF7IP2 VPS13A | 8.11e-05 | 776 | 160 | 17 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_100 | 1.21e-04 | 34 | 160 | 4 | gudmap_developingGonad_e14.5_ ovary_100_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.38e-04 | 104 | 160 | 6 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_500 | 1.51e-04 | 67 | 160 | 5 | gudmap_developingGonad_e12.5_ovary_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 1.57e-04 | 152 | 160 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.61e-04 | 107 | 160 | 6 | gudmap_developingGonad_e16.5_ovary_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.38e-04 | 115 | 160 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | 2.44e-04 | 402 | 160 | 11 | GSM791105_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | CENPF MEIOB TUBA3E CHEK1 ATP10A TFRC BRCA2 TAF7L ATF7IP2 PAK1 DNA2 | 2.65e-04 | 406 | 160 | 11 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-09 | 184 | 161 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-09 | 184 | 161 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-09 | 184 | 161 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-07 | 175 | 161 | 8 | 901f0181a30e5cc609dcada8d8a59f0468df6fa5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 195 | 161 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 195 | 161 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-07 | 198 | 161 | 8 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 6.45e-07 | 198 | 161 | 8 | 5c92687b853ebb00960adbef6552f9d460bc6886 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 156 | 161 | 7 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-06 | 158 | 161 | 7 | ad0e2371c0bc6e53d22518aa3a401cddcde3759f | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.38e-06 | 165 | 161 | 7 | d2ab667ff53f538b12ee4e07ea4b4d118600a228 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-06 | 168 | 161 | 7 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Megakaryocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.79e-06 | 169 | 161 | 7 | d571e84e01e3316748d4407ed98881b17484e035 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.91e-06 | 170 | 161 | 7 | 3886a77bc3ddbeb42a8149b759fe578871676d6e | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.91e-06 | 170 | 161 | 7 | eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Megakaryocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.02e-06 | 171 | 161 | 7 | 9dda25df493766723335851b3c3d89735b6e8051 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-06 | 174 | 161 | 7 | a75ba49ccea6bd3d78ada1092b46deb5202c58a5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.52e-06 | 175 | 161 | 7 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.52e-06 | 175 | 161 | 7 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 177 | 161 | 7 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 177 | 161 | 7 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-06 | 179 | 161 | 7 | 8d9bad6507fac0926163807a0bda62a57e7660e3 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 180 | 161 | 7 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 180 | 161 | 7 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.24e-06 | 180 | 161 | 7 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 182 | 161 | 7 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 4.72e-06 | 183 | 161 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.26e-06 | 186 | 161 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 5.64e-06 | 188 | 161 | 7 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 6.04e-06 | 190 | 161 | 7 | 468525c05e38158a3b8a445882b2d63dfb1d2c63 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.25e-06 | 191 | 161 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 6.69e-06 | 193 | 161 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.69e-06 | 193 | 161 | 7 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.16e-06 | 195 | 161 | 7 | 7bb3bdfb8caaae357b1f7841d8d00936c4373dfe | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.16e-06 | 195 | 161 | 7 | d579150d176e6bd81004b5146de4901ca13a3c3e | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.91e-06 | 198 | 161 | 7 | f486747f2c96b403bdeee0dfe0cc2679ffeefa33 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.91e-06 | 198 | 161 | 7 | 2e669da80363163b806f23a645474d482797ae5d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-06 | 198 | 161 | 7 | 428182c71f009906c581e02257e545ea5fb99650 | |
| ToppCell | myeloid-pro-cDC|World / Lineage and Cell class | 8.17e-06 | 199 | 161 | 7 | 05652da8747d608b515324f90b3a70155a9c9898 | |
| ToppCell | (5)_Plasma-(5)_Plasmablast|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.45e-06 | 200 | 161 | 7 | bba54e9acc7514e123de083a4eb49e7bcdb3dac3 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.45e-06 | 200 | 161 | 7 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 8.45e-06 | 200 | 161 | 7 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.45e-06 | 200 | 161 | 7 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.45e-06 | 200 | 161 | 7 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.79e-05 | 150 | 161 | 6 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | VE-CD8-memory_CD4|VE / Condition, Cell_class and T cell subcluster | 1.93e-05 | 152 | 161 | 6 | 9401b7770c1bdc87eba25e82922f5dd1c4fa37ee | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-05 | 153 | 161 | 6 | c4dcdcaa672929c1da870e9fb8ada1bb030ad12f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 158 | 161 | 6 | cf1b77abd05f18526679c0d305b4dd2caef2b306 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 160 | 161 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 160 | 161 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.76e-05 | 162 | 161 | 6 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-05 | 163 | 161 | 6 | 6c4d4c55fc8a731acca13c1ba7287f238a9d81e0 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.16e-05 | 166 | 161 | 6 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 167 | 161 | 6 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 167 | 161 | 6 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 167 | 161 | 6 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-05 | 168 | 161 | 6 | 9d6ca10c272aea28082c09d469940f7232f6461c | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.62e-05 | 170 | 161 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-05 | 103 | 161 | 5 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-05 | 171 | 161 | 6 | 1efce222989460bb59bd9fa955e7d9a60c73994c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 171 | 161 | 6 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 171 | 161 | 6 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.86e-05 | 172 | 161 | 6 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-05 | 172 | 161 | 6 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-05 | 174 | 161 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.25e-05 | 175 | 161 | 6 | c33317d8d60ea88ec326daf91dfd3416a62f9938 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 4.39e-05 | 176 | 161 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.39e-05 | 176 | 161 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.53e-05 | 177 | 161 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 177 | 161 | 6 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 177 | 161 | 6 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 178 | 161 | 6 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 178 | 161 | 6 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 179 | 161 | 6 | 69c74b2ff43b43653005807654953daf21f932ec | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.13e-05 | 181 | 161 | 6 | d74ee84146a72fd7cddf287f2e66d47d2c683bc4 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 5.29e-05 | 182 | 161 | 6 | 6745d464c3ff289726aa8164e9a43f407f8e4380 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 5.62e-05 | 184 | 161 | 6 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|Mesenchymal_cells / Lineage and Cell class | 5.62e-05 | 184 | 161 | 6 | 83987abaedc26e6da477bc70d65e10b1ab1aea60 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.79e-05 | 185 | 161 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Solid_Pattern_Predominant_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.91e-05 | 114 | 161 | 5 | 9c304f7a8584baccb591a873c67c5b57945cce44 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.96e-05 | 186 | 161 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 186 | 161 | 6 | d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.96e-05 | 186 | 161 | 6 | 1c39ced3b32dba2832991284720b6c5f508a2e73 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.14e-05 | 187 | 161 | 6 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 187 | 161 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.14e-05 | 187 | 161 | 6 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | remission-Platelet|World / disease stage, cell group and cell class | 6.33e-05 | 188 | 161 | 6 | fa69f20ef6b8ce620ba342f0984d40ddf259bc3f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.33e-05 | 188 | 161 | 6 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | 6.33e-05 | 188 | 161 | 6 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.52e-05 | 189 | 161 | 6 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 6.52e-05 | 189 | 161 | 6 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.52e-05 | 189 | 161 | 6 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 6.71e-05 | 190 | 161 | 6 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_fh|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.71e-05 | 190 | 161 | 6 | 120ca702600373c208a3d032fede0a040736e5cf | |
| ToppCell | Caecum-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 6.71e-05 | 190 | 161 | 6 | 54463f6f1718f22704175bd034f134de3b55d2eb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-05 | 190 | 161 | 6 | b69940d16685249167d4c2cf6ad8237ccf6f7590 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 6.71e-05 | 190 | 161 | 6 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.71e-05 | 190 | 161 | 6 | 13dc3a0aaa554f63eabac37726bd1f11b66fb3dd | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 190 | 161 | 6 | 4288189e3a499c395896c950598810b02f401685 | |
| Drug | Epothilone D | 1.02e-10 | 12 | 161 | 6 | DB01873 | |
| Drug | Epothilone B | 1.02e-10 | 12 | 161 | 6 | DB03010 | |
| Drug | magnesium sulfate | 3.03e-09 | 52 | 161 | 8 | CID000024083 | |
| Drug | NSC292222 | 2.98e-08 | 27 | 161 | 6 | CID000099957 | |
| Drug | AC1NBBHE | 5.88e-08 | 30 | 161 | 6 | CID004490620 | |
| Drug | NSC376450 | 1.30e-07 | 34 | 161 | 6 | CID000005605 | |
| Drug | erianin | 3.06e-07 | 39 | 161 | 6 | CID000356759 | |
| Drug | bromocolchicine | 3.08e-07 | 21 | 161 | 5 | CID000161518 | |
| Drug | colchifoline | 3.08e-07 | 21 | 161 | 5 | CID000100132 | |
| Drug | Ustiloxin A | 3.08e-07 | 21 | 161 | 5 | CID000164454 | |
| Drug | SRI-3072 | 3.08e-07 | 21 | 161 | 5 | CID000493469 | |
| Drug | 3,4,5-trimethoxyacetophenone | 3.97e-07 | 22 | 161 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 3.97e-07 | 22 | 161 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 3.97e-07 | 22 | 161 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 3.97e-07 | 22 | 161 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 3.97e-07 | 22 | 161 | 5 | CID000023759 | |
| Drug | NSC-339672 | 3.97e-07 | 22 | 161 | 5 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 5.04e-07 | 23 | 161 | 5 | CID000006858 | |
| Drug | AC1L2P05 | 5.04e-07 | 23 | 161 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 5.04e-07 | 23 | 161 | 5 | CID000125548 | |
| Drug | NSC-373301 | 5.04e-07 | 23 | 161 | 5 | CID000341375 | |
| Drug | NSC355636 | 5.04e-07 | 23 | 161 | 5 | CID000100176 | |
| Drug | IKP104 | 5.04e-07 | 23 | 161 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 5.04e-07 | 23 | 161 | 5 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 5.04e-07 | 23 | 161 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 5.04e-07 | 23 | 161 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 5.04e-07 | 23 | 161 | 5 | CID000097865 | |
| Drug | parbendazole | 6.33e-07 | 24 | 161 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 6.33e-07 | 24 | 161 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 6.33e-07 | 24 | 161 | 5 | CID000330401 | |
| Drug | NABV | 6.33e-07 | 24 | 161 | 5 | CID000175959 | |
| Drug | AC1L4TG7 | 6.33e-07 | 24 | 161 | 5 | CID000163705 | |
| Drug | moscatilin | 6.33e-07 | 24 | 161 | 5 | CID000176096 | |
| Drug | NSC-36768 | 6.33e-07 | 24 | 161 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 6.33e-07 | 24 | 161 | 5 | CID000014995 | |
| Drug | colchicide | 6.33e-07 | 24 | 161 | 5 | CID000120712 | |
| Drug | mpMap | 7.87e-07 | 25 | 161 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 7.87e-07 | 25 | 161 | 5 | CID000160263 | |
| Drug | allocolchicine | 7.87e-07 | 25 | 161 | 5 | CID000196989 | |
| Drug | 1069C85 | 7.87e-07 | 25 | 161 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 7.87e-07 | 25 | 161 | 5 | CID006438440 | |
| Drug | MDL 27048 | 7.87e-07 | 25 | 161 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 7.87e-07 | 25 | 161 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 7.87e-07 | 25 | 161 | 5 | CID000043264 | |
| Drug | CA1P | 7.87e-07 | 25 | 161 | 5 | CID006918545 | |
| Drug | peloruside A | 7.87e-07 | 25 | 161 | 5 | CID006918506 | |
| Drug | NSC142227 | 7.87e-07 | 25 | 161 | 5 | CID000073427 | |
| Drug | dimethylarsinic acid | 9.46e-07 | 107 | 161 | 8 | CID000002513 | |
| Drug | NSC527981 | 9.69e-07 | 26 | 161 | 5 | CID000352796 | |
| Drug | NSC332029 | 9.69e-07 | 26 | 161 | 5 | CID000100073 | |
| Drug | indibulin | 9.69e-07 | 26 | 161 | 5 | CID000002929 | |
| Drug | pironetin | 9.69e-07 | 26 | 161 | 5 | CID006438891 | |
| Drug | isaxonine | 9.69e-07 | 26 | 161 | 5 | CID000071169 | |
| Drug | AC1L1J4H | 1.18e-06 | 27 | 161 | 5 | CID000004862 | |
| Drug | dinitroanilines | 1.18e-06 | 27 | 161 | 5 | CID000136400 | |
| Drug | NSC D-669356 | 1.18e-06 | 27 | 161 | 5 | CID000178028 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.38e-06 | 4 | 161 | 3 | DB07574 | |
| Drug | GaCl3 | 1.40e-06 | 50 | 161 | 6 | CID000026010 | |
| Drug | Z)-combretastatin A-4 | 1.40e-06 | 50 | 161 | 6 | CID000072686 | |
| Drug | NSC 370147 | 1.43e-06 | 28 | 161 | 5 | CID000182762 | |
| Drug | NSC72302 | 1.43e-06 | 28 | 161 | 5 | CID000118078 | |
| Drug | bp U | 1.72e-06 | 29 | 161 | 5 | CID000368697 | |
| Drug | oxibendazole | 1.72e-06 | 29 | 161 | 5 | CID000004622 | |
| Drug | Aids106696 | 1.72e-06 | 29 | 161 | 5 | CID006475933 | |
| Drug | ddGDP | 1.72e-06 | 29 | 161 | 5 | CID000134739 | |
| Drug | eleutherobin | 2.05e-06 | 30 | 161 | 5 | CID006918335 | |
| Drug | azatoxin | 2.05e-06 | 30 | 161 | 5 | CID000125383 | |
| Drug | NSC617668 | 2.05e-06 | 30 | 161 | 5 | CID000357989 | |
| Drug | citostal | 2.05e-06 | 30 | 161 | 5 | CID000018991 | |
| Drug | thiocolchicine | 2.05e-06 | 30 | 161 | 5 | CID000017648 | |
| Drug | S)-monastrol | 2.22e-06 | 54 | 161 | 6 | CID000794323 | |
| Drug | NSC609395 | 2.43e-06 | 31 | 161 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 2.43e-06 | 31 | 161 | 5 | CID000100524 | |
| Drug | AC7700 | 2.43e-06 | 31 | 161 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 2.43e-06 | 31 | 161 | 5 | CID000032851 | |
| Drug | tropone | 2.43e-06 | 31 | 161 | 5 | CID000010881 | |
| Drug | AC1L3V8I | 2.43e-06 | 31 | 161 | 5 | CID000122777 | |
| Drug | NSC332598 | 2.43e-06 | 31 | 161 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 2.43e-06 | 31 | 161 | 5 | CID000023678 | |
| Drug | AC1L1G95 | 2.87e-06 | 32 | 161 | 5 | CID000003583 | |
| Drug | NSC153858 | 2.87e-06 | 32 | 161 | 5 | CID000547450 | |
| Drug | E2-3,4-Q | 2.87e-06 | 32 | 161 | 5 | CID000067402 | |
| Drug | 2-demethylcolchicine | 2.87e-06 | 32 | 161 | 5 | CID000023757 | |
| Drug | mebendazole | 3.36e-06 | 33 | 161 | 5 | CID000004030 | |
| Drug | CA4P | 3.36e-06 | 33 | 161 | 5 | CID000370232 | |
| Drug | taltobulin | 3.36e-06 | 33 | 161 | 5 | CID006918637 | |
| Drug | moperone | 3.43e-06 | 5 | 161 | 3 | CID000004249 | |
| Drug | triethyllead | 3.92e-06 | 34 | 161 | 5 | CID006328106 | |
| Drug | 2-phenyl-4-quinolone | 3.92e-06 | 34 | 161 | 5 | CID000161091 | |
| Drug | discodermolide | 4.54e-06 | 35 | 161 | 5 | CID000643668 | |
| Drug | lanthanum | 5.74e-06 | 136 | 161 | 8 | CID000023926 | |
| Drug | AC1O5Y0F | 6.03e-06 | 37 | 161 | 5 | CID006442852 | |
| Drug | DTAF | 6.03e-06 | 37 | 161 | 5 | CID000123934 | |
| Drug | albendazole | 6.03e-06 | 37 | 161 | 5 | CID000002082 | |
| Drug | baccatin III | 6.03e-06 | 37 | 161 | 5 | CID000065366 | |
| Drug | carpipramine | 6.83e-06 | 6 | 161 | 3 | CID000002580 | |
| Drug | gnoscopine | 6.91e-06 | 38 | 161 | 5 | CID000004544 | |
| Drug | laulimalide | 6.91e-06 | 38 | 161 | 5 | CID006918457 | |
| Drug | colchiceine | 6.91e-06 | 38 | 161 | 5 | CID000010156 | |
| Drug | Dolastatin 10 | 7.88e-06 | 39 | 161 | 5 | CID000100208 | |
| Disease | microlissencephaly (implicated_via_orthology) | 4.58e-19 | 8 | 154 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 4.58e-19 | 8 | 154 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 4.58e-19 | 8 | 154 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 9.35e-13 | 27 | 154 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 2A2A (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0110155 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 2A2B (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0111557 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease, type 2A | 2.71e-05 | 2 | 154 | 2 | cv:C2079538 | |
| Disease | nervous system disease (implicated_via_orthology) | 2.96e-05 | 12 | 154 | 3 | DOID:863 (implicated_via_orthology) | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 5.64e-05 | 78 | 154 | 5 | EFO_0022187 | |
| Disease | Brody myopathy (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Disruptive, Impulse Control, and Conduct Disorders | 8.09e-05 | 3 | 154 | 2 | C0021122 | |
| Disease | polycystic kidney disease 2 (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:0110859 (implicated_via_orthology) | |
| Disease | Intermittent Explosive Disorder | 8.09e-05 | 3 | 154 | 2 | C0021776 | |
| Disease | Breast Carcinoma | CENPF DYNC2H1 CHEK1 CPT1A INPP4B TFRC BRCA2 MKI67 PAK1 SMARCD1 TP53BP1 | 1.29e-04 | 538 | 154 | 11 | C0678222 |
| Disease | Charcot-Marie-Tooth disease type 2 (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:0050539 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | CENPF DYNC2H1 CHEK1 CPT1A INPP4B TFRC BRCA2 MKI67 PAK1 SMARCD1 LRRC7 OXSM ATP2A3 RUSF1 TP53BP1 SLC17A6 | 1.65e-04 | 1074 | 154 | 16 | C0006142 |
| Disease | unipolar depression | DRD2 HIVEP2 RNF152 DYNC2H1 PCLO BTN2A1 BPNT1 GSDME DDX50 ASXL3 RXFP2 TRIM8 PRKCSH LY75 ATP2A2 LY86 LINC02915 | 1.97e-04 | 1206 | 154 | 17 | EFO_0003761 |
| Disease | heroin dependence (biomarker_via_orthology) | 2.68e-04 | 5 | 154 | 2 | DOID:9976 (biomarker_via_orthology) | |
| Disease | parental longevity | 2.83e-04 | 494 | 154 | 10 | EFO_0007796 | |
| Disease | lipid metabolism disorder (is_implicated_in) | 4.00e-04 | 6 | 154 | 2 | DOID:3146 (is_implicated_in) | |
| Disease | migraine with aura (is_implicated_in) | 4.00e-04 | 6 | 154 | 2 | DOID:10024 (is_implicated_in) | |
| Disease | Alzheimer's disease (is_marker_for) | 4.20e-04 | 257 | 154 | 7 | DOID:10652 (is_marker_for) | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 5.59e-04 | 7 | 154 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Akinetic Petit Mal | 5.59e-04 | 7 | 154 | 2 | C0001890 | |
| Disease | Epilepsy, Absence, Atypical | 5.59e-04 | 7 | 154 | 2 | C0751124 | |
| Disease | Absence Seizure Disorder | 5.59e-04 | 7 | 154 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 5.59e-04 | 7 | 154 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 5.59e-04 | 7 | 154 | 2 | C4281785 | |
| Disease | Epilepsy, Minor | 5.59e-04 | 7 | 154 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 5.59e-04 | 7 | 154 | 2 | C0014553 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.76e-04 | 195 | 154 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | primary pulmonary hypertension (is_marker_for) | 7.42e-04 | 8 | 154 | 2 | DOID:14557 (is_marker_for) | |
| Disease | periodontal disease (biomarker_via_orthology) | 7.42e-04 | 8 | 154 | 2 | DOID:3388 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 8.29e-04 | 80 | 154 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Cardiomegaly | 9.10e-04 | 82 | 154 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 9.10e-04 | 82 | 154 | 4 | C1383860 | |
| Disease | Bipolar Disorder | 9.39e-04 | 477 | 154 | 9 | C0005586 | |
| Disease | vitamin K measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0004618 | |
| Disease | Recurrent depression | 9.51e-04 | 9 | 154 | 2 | C0221480 | |
| Disease | Disorder of fatty acid metabolism | 9.51e-04 | 9 | 154 | 2 | cv:C0268634 | |
| Disease | response to risperidone | 1.03e-03 | 38 | 154 | 3 | GO_0097336 | |
| Disease | Seizures | 1.03e-03 | 218 | 154 | 6 | C0036572 | |
| Disease | breast cancer (is_implicated_in) | 1.17e-03 | 150 | 154 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | Delirium | 1.18e-03 | 10 | 154 | 2 | C0011206 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.28e-03 | 41 | 154 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.28e-03 | 41 | 154 | 3 | C0858252 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.43e-03 | 157 | 154 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | ovary epithelial cancer (is_implicated_in) | 1.44e-03 | 11 | 154 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | lignoceroylcarnitine (C24) measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0800541 | |
| Disease | Lenticulostriate Disorders | 1.73e-03 | 12 | 154 | 2 | C0750951 | |
| Disease | Cooley's anemia | 1.73e-03 | 12 | 154 | 2 | C0002875 | |
| Disease | Thalassemia Intermedia | 1.73e-03 | 12 | 154 | 2 | C0271979 | |
| Disease | Extrapyramidal Disorders | 1.73e-03 | 12 | 154 | 2 | C0015371 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.73e-03 | 12 | 154 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Thalassemia Minor | 1.73e-03 | 12 | 154 | 2 | C0085578 | |
| Disease | Basal Ganglia Diseases | 1.73e-03 | 12 | 154 | 2 | C0004782 | |
| Disease | beta Thalassemia | 1.73e-03 | 12 | 154 | 2 | C0005283 | |
| Disease | Major Depressive Disorder | 1.79e-03 | 243 | 154 | 6 | C1269683 | |
| Disease | Mammary Carcinoma, Human | 1.82e-03 | 525 | 154 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.82e-03 | 525 | 154 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 1.86e-03 | 527 | 154 | 9 | C1458155 | |
| Disease | Mood Disorders | 1.93e-03 | 168 | 154 | 5 | C0525045 | |
| Disease | mean corpuscular hemoglobin concentration | CYC1 MAPK8IP1 AGO2 TUBA1C IREB2 TRIM34 TSHR DMXL1 TFRC AGO4 THG1L VPS13A LY75 RUSF1 | 2.01e-03 | 1105 | 154 | 14 | EFO_0004528 |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.36e-03 | 14 | 154 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.42e-03 | 51 | 154 | 3 | EFO_0022302 | |
| Disease | Unipolar Depression | 2.46e-03 | 259 | 154 | 6 | C0041696 | |
| Disease | Intellectual Disability | 2.49e-03 | 447 | 154 | 8 | C3714756 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 2.55e-03 | 52 | 154 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | Dyskinesia, Medication-Induced | 2.72e-03 | 15 | 154 | 2 | C0751088 | |
| Disease | glycerate measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0021029 | |
| Disease | Dyskinesia, Drug-Induced | 2.72e-03 | 15 | 154 | 2 | C0013386 | |
| Disease | Hemoglobin F Disease | 2.72e-03 | 15 | 154 | 2 | C0019025 | |
| Disease | pancreatic cancer (is_implicated_in) | 2.86e-03 | 112 | 154 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | neuroticism measurement, cognitive function measurement | 3.00e-03 | 566 | 154 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | uterine prolapse | 3.10e-03 | 16 | 154 | 2 | EFO_1001864 | |
| Disease | cholesteryl ester 16:1 measurement | 3.10e-03 | 16 | 154 | 2 | EFO_0010342 | |
| Disease | triglycerides in LDL measurement | 3.16e-03 | 56 | 154 | 3 | EFO_0022320 | |
| Disease | Cocaine-Related Disorders | 3.35e-03 | 117 | 154 | 4 | C0236736 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 3.50e-03 | 17 | 154 | 2 | cv:C0270914 | |
| Disease | multiple myeloma (is_implicated_in) | 3.66e-03 | 59 | 154 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.92e-03 | 18 | 154 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | disease progression measurement | 4.02e-03 | 61 | 154 | 3 | EFO_0008336 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.07e-03 | 200 | 154 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 4.07e-03 | 200 | 154 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | triglycerides in medium LDL measurement | 4.21e-03 | 62 | 154 | 3 | EFO_0022322 | |
| Disease | Pancreatic carcinoma | 4.37e-03 | 19 | 154 | 2 | C0235974 | |
| Disease | lingual gyrus volume measurement | 4.37e-03 | 19 | 154 | 2 | EFO_0010314 | |
| Disease | Cocaine Abuse | 4.49e-03 | 127 | 154 | 4 | C0009171 | |
| Disease | triglycerides in small LDL measurement | 4.81e-03 | 65 | 154 | 3 | EFO_0022323 | |
| Disease | mean arterial pressure | 4.82e-03 | 499 | 154 | 8 | EFO_0006340 | |
| Disease | white matter integrity | 4.87e-03 | 130 | 154 | 4 | EFO_0004641 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLSSCDAVKMTIIRD | 641 | Q99569 | |
| QQCVIMAENRKSSII | 71 | Q02325 | |
| MLDCRTSLSAKVNNA | 226 | Q9Y277 | |
| ISTNCRTAEKMALTL | 241 | Q8N9N5 | |
| TTMERKLCSQTSLAE | 901 | Q68DN1 | |
| VRQKCQDETQMISSL | 466 | Q9UBC2 | |
| LICNNMVTSTRAIVN | 3106 | Q9NR09 | |
| KSCMNQVTISTTDRR | 406 | O14757 | |
| MKTIQRCNTGERSLS | 66 | P29965 | |
| RCNQCSQLLITMTDK | 231 | Q96Q42 | |
| MSTTGQVIRCKAAIL | 1 | P28332 | |
| RNEVLCVLTQKITTM | 151 | O60443 | |
| ELVMQQLRSLQSSSC | 346 | Q6ZMN8 | |
| KINRTLETANCMSSQ | 86 | P50416 | |
| LETANCMSSQTKNVV | 91 | P50416 | |
| TEMLRAQVSALESKC | 846 | Q9UDT6 | |
| ILQCMKTDSIQNRTA | 161 | Q96C12 | |
| TLTQNIMTFKRCSIN | 396 | Q8TF62 | |
| ATMSQIAKDVCTFLR | 261 | P08574 | |
| QRCIKKLTDNQTSTM | 351 | Q9H9G7 | |
| RCIKKLTDNQTSTMI | 341 | Q9HCK5 | |
| LQTKADRLAQMSICS | 46 | O95861 | |
| TLTRSMTSLAQKICG | 1281 | Q9Y485 | |
| DKTGTLTTNQMSVCR | 351 | Q93084 | |
| NTTISACNISMLKTI | 1271 | Q9C0F0 | |
| TLTENKMVFRRCTVS | 431 | O60312 | |
| RCIKKLTDNQTSTMI | 351 | Q9UKV8 | |
| ATMKTLTIDCVQFQR | 436 | P23786 | |
| TSMKRLLSRHVVCQV | 296 | A0A096LPK9 | |
| TRSKAMRTVTNIFIC | 71 | Q96P65 | |
| SQLSIVDRTTIANMC | 361 | P48200 | |
| MKRQNVRTLSLIVCT | 1 | Q9NPC2 | |
| TEKLRMIVSSTSANC | 651 | Q8IWA4 | |
| FRNCMTATVISKTII | 241 | Q8N635 | |
| MSNCLQNFLKITSTR | 1 | Q9NWU1 | |
| SSIQMQLKQSTCEAV | 211 | P40426 | |
| QLKQSTCEAVMILRS | 216 | P40426 | |
| LKQSTCEAVMILRSR | 226 | P40425 | |
| LCFQATQTARKMLSQ | 86 | A9QM74 | |
| RICEMIQKSVSSDLQ | 196 | P18428 | |
| LKQATAVRCLDMSAS | 511 | Q9HBG6 | |
| QIVSVMSSRRNCETN | 916 | Q8IV33 | |
| TEKRSTVACANATIM | 146 | O95711 | |
| FKNMVIVTTTTECLR | 271 | Q9NPP4 | |
| IGSCKNVTVMSLRSN | 341 | Q96NW7 | |
| LCAAMQKIATTRRLT | 586 | Q9UQF2 | |
| NRSTTVRLLCGKETM | 476 | P14314 | |
| NSRETSKESKCIIQM | 16 | O60333 | |
| KDRTSMSVTLEQCSI | 846 | O15327 | |
| LLVSETSCQVSNRAM | 536 | Q9H9K5 | |
| TSCQVSNRAMKGLTT | 541 | Q9H9K5 | |
| RGLSSKTLCMESQQI | 2351 | O43451 | |
| SRLQTVTAQVKMCLN | 776 | Q12766 | |
| ICRTNTMARAKILQD | 3751 | Q9Y6V0 | |
| LCTKATMQTVRAADT | 246 | Q14642 | |
| RQKALSTCSSHMTVV | 231 | Q6IF82 | |
| ISQEQRLKALNTCMS | 231 | Q9H343 | |
| SQTVQRMLVAASLAC | 146 | P47893 | |
| TSMKRLLSRHVVCQV | 296 | Q8N0Y3 | |
| ICTSSLQVQRRFKAM | 201 | Q6P2I7 | |
| KCESNTVTQSRLMSI | 371 | O94915 | |
| CQDVISMTANRLSAV | 441 | Q8IYU2 | |
| SSQVSSAVMKSLLCL | 991 | Q14005 | |
| LDITKSVNELRMFSC | 86 | O60449 | |
| SAKRECLKSNMQLVS | 1126 | O60449 | |
| NVCIDSMSVNLTRRT | 241 | P18074 | |
| TIRILTCQKTELQMA | 131 | Q8N7Z2 | |
| HTIRILTCQKTELQM | 81 | H0YM25 | |
| ISRSQHDILQMICSK | 631 | P46013 | |
| QMTTSERRKIFCSVT | 146 | Q8TCQ1 | |
| MSLLFSRCNSIVTVK | 1 | O95140 | |
| SRLICSAKQQQTMLR | 911 | Q6VY07 | |
| KLMTLVDTSINIECR | 3351 | Q96RW7 | |
| CVKTLCSRRVNMIQT | 1116 | Q92729 | |
| MLVQKNVTSESTCCV | 71 | P01215 | |
| QRLKEAQNTCAMLTT | 236 | P36957 | |
| CAQITPEQSKRSTMV | 411 | Q13153 | |
| CRSVRTVKQMQVSLT | 361 | P55085 | |
| QLKQSTCEAVMTLRS | 191 | Q9BYU1 | |
| RSSSVKSLSQEMRCT | 21 | A2A2Y4 | |
| VKEVIASTNCNLTMS | 2056 | Q9P2D7 | |
| LSQTCMVISTNTGRV | 2331 | Q8NCM8 | |
| IKDRVTITNCLLMNS | 381 | Q9NR50 | |
| DKTGTLTTNQMSVCR | 351 | P16615 | |
| ICSDKTGTLTQNRMT | 371 | P50993 | |
| NSMNSLRKSNTLCDV | 21 | Q53G59 | |
| ENQMTILKTTSEECR | 1146 | P51587 | |
| FTRMQNECKQLISSL | 771 | O14981 | |
| LNDSRSECITATRKM | 1321 | P49454 | |
| MKTNTISREEFRAIC | 1191 | Q5THR3 | |
| TTIQETVKVNTRMQC | 456 | Q14393 | |
| ETRMVALCTCKATQR | 91 | P0C7P0 | |
| MESRNSCLIKRVTSV | 351 | Q53R41 | |
| KLSSNAVSQITRMCL | 611 | Q9BQ39 | |
| CDLASMTSIRQFVQK | 101 | Q8N5I4 | |
| AVIIRDKSVRNMSCS | 206 | Q7KYR7 | |
| DKSVRNMSCSINNTL | 211 | Q7KYR7 | |
| VNVSSIMSVRALKSC | 136 | P16152 | |
| RMKTSEQINENICVS | 296 | Q5U623 | |
| NVKSLQELCRMESKT | 646 | Q9Y4F3 | |
| AARQMRKCEQSTSAT | 241 | Q92551 | |
| ATCKQITSADAVRNM | 536 | O95834 | |
| SAVSSKMVRQILELC | 341 | Q9UKA1 | |
| CMAVSREKALQTTTN | 56 | P14416 | |
| LQTICQMASSSRNLV | 2391 | P35556 | |
| QMASSSRNLVTKSEC | 2396 | P35556 | |
| TSLSEECKRQMLTAS | 966 | Q14289 | |
| QKCLTSTEIMRIQRE | 191 | Q9NVP4 | |
| KKNCSVRTASRQTSM | 416 | Q9NW75 | |
| RELQTTELKMCSLAV | 1046 | O95180 | |
| TIVDTLCTNMRSDKE | 86 | O75155 | |
| KEINMTTVTCLLDRN | 536 | P51530 | |
| CMAVLKERALQTTTN | 51 | P35462 | |
| MTCTDINTLTRQKEL | 241 | Q5BJF6 | |
| MQVSIACTEQNLRSR | 1 | O43448 | |
| KVNICMSRIKSTLNS | 96 | Q9NP80 | |
| SKTTMRINKQDALCT | 6 | Q8N9W8 | |
| MTVSTSNLAKCIVSV | 191 | Q96GQ5 | |
| ACTVRNLARSQSVKM | 111 | Q5H9L4 | |
| RIMETASKSQTLCSE | 646 | Q2M3C7 | |
| RACITVSNKEAVTSM | 36 | Q9BYJ4 | |
| KMTNSCLKRSENSRI | 31 | P0C7P3 | |
| SVCLQQMRTSQKDVR | 36 | Q8N8N0 | |
| QINSSLVDSNMLVRC | 616 | Q8TEL6 | |
| LQSQCRDLKTMTDVV | 456 | Q96GM5 | |
| CSTKDTFMTELLNRV | 1611 | O14513 | |
| MLRFIQEVNTTTRSC | 76 | Q8NAU1 | |
| STFLRKNQCETRTML | 81 | P41222 | |
| TMFCSIQKTALQTTE | 611 | Q8WXD0 | |
| KITQSLMASVNSTCN | 136 | Q9UIB8 | |
| IETVINMLCNSRSKL | 296 | Q6UW49 | |
| QQCVIMAENRKSSII | 71 | P00747 | |
| SLRNVSCEVDMFKTL | 366 | Q8TCS8 | |
| STCRMVTSESKNVKL | 361 | P02786 | |
| VAMNRAQVCLISSSK | 566 | Q9Y5Q9 | |
| NSTNVQMVDSRISCK | 136 | P62324 | |
| ICSDKTGTLTQNRMT | 381 | Q13733 | |
| NMSSTKRVCTILADS | 131 | Q8N8G6 | |
| QSSRDIMQSKSACEI | 2486 | A4UGR9 | |
| KQILSTTTVRKIMNC | 376 | Q9P2U8 | |
| VQRAVCMLSNTTAIA | 371 | P0DPH8 | |
| RVCKESFSTNMLLIE | 236 | Q9UID6 | |
| TRKLQKQDCSVNMTT | 866 | Q96RL7 | |
| LSQVMRTCQQLSVSD | 111 | Q19AV6 | |
| VEISLTCKNRVQNMA | 51 | P51571 | |
| LRTKALSMLTEAVQC | 1691 | Q15413 | |
| DSRALQLMTKCAQTV | 76 | Q9NWX6 | |
| LIMINACKIASSSRV | 71 | P11908 | |
| VQRAVCMLSNTTAIA | 371 | P0DPH7 | |
| TFISCSNLTVLVMRK | 266 | Q9HBX9 | |
| KTMSVLSCICEARQE | 1031 | Q12888 | |
| KTMSQLSSTLSRCVK | 391 | Q9NZM6 | |
| KTMTQLSSTLARCAK | 461 | Q9P0L9 | |
| VQRAVCMLSNTTAIA | 371 | Q71U36 | |
| VQRAVCMLSNTTAIA | 371 | Q6PEY2 | |
| SNCSMLSERKDVLTA | 186 | O94901 | |
| VQRAVCMLSNTTAIA | 371 | P68363 | |
| ICKVDENMTQRTLVT | 1366 | P31629 | |
| TCKITNCSERTMDLV | 326 | A5PLN9 | |
| NTKSVKILMDRTQTC | 301 | Q9BZR9 | |
| KILMDRTQTCTSSSL | 306 | Q9BZR9 | |
| CAIKSLSRITEMQQV | 1111 | Q04912 | |
| VQRAVCMLSNTTAVA | 371 | Q9BQE3 | |
| KQSCRSSLAELMART | 951 | Q9ULE0 | |
| VQRAVCMLSNTTAIA | 371 | Q9NY65 | |
| VQRAVCMLSNTTAIA | 371 | P68366 | |
| QILTTTAVRKIMNCG | 381 | Q8NDX2 | |
| CNESSMQSLRQRKSV | 301 | P16473 | |
| KSMENLQSCISLRVC | 41 | A6PVS8 | |
| RSLRKSDSVQLVCMA | 2506 | Q9NR99 | |
| SIRSMLATSSQELKC | 891 | Q9UL68 |